Replies to post #8787 on PharmaRoth Labs, Inc. (ROTH)

[sweetlou]

Once again, the comments 'not to be trusted', 'paid insider', 'not independent peer review' are false and show complete ignorance of scientific literature and definitions


1. Dr. Rojas is not an insider. See the definition below:

http://www.investopedia.com/terms/i/insider.asp

2. The trials of Sucanon in Mexico City have been separately represented by you as "nonexistent" or "sham" and state the press release "may never come out" or is "another lie". Those statements are without basis in either fact or logic. If the trials are nonexistent then there need be no discussion about how they were paid for. Delays occur for many reasons and the results will be announced when data review is completed.

3. The multiple attempts to discredit Sucanon and Dr Rojas have been exposed in detail as false. A brief review is as follows:
A. Preclinical and double blind placebo controlled studies were done before involvement of Dr Rojas, (or Irving, Hall or others you implicate). They showed Sucanon outperformed Glyburide in humans and several classes of oral diabetes medications in rats.
B. Dr. Rojas has been viciously attacked (ethical smears, statements that he could lose his license etc) here for acting as a consultant to the company, an allowable situation under medical society regulations. This information has been repeatedly posted and is verifiable from multiple sources referenced in my posts.

4. As previously documented and proven, independent peer review of the Latino prediabetic Sucanon study was done prior to the presentation at 2013 EASD annual meeting and publication in their journal.